Abstract
L-Asparaginase (L-asparagine amidohydrolase, E.C.3.5.1.1) catalyzes the hydrolysis of L-asparagine to yield L-aspartic acid and ammonia. The enzyme was first reported by Lang (1904), who demonstrated its activity in various beef tissues. Confirmatory observations with tissues from horse and pig were reported a few years later by Von Furth and Friedmann (1910). The observation most pertinent to the current discussion, however, was that of Clementi (1921, 1922), who found that of numerous blood sera tested only that of the guinea pig showed L-asparaginase activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abdou, N. I., Richter, M.: The role of bone marrow in the immune response. Advanc. Immunol. 12, 201–270 (1970).
Adamson, R. H., Fabro, S.: Antitumor activity and other biologic properties of L-asparaginase (NSC-109229) — A review. Cancer Chemother. Rep. 52, 617–626 (1968a).
Adamson, R. H., Fabro, S.: Embryotoxic effect of L-asparaginase. Nature (Lond.) 218, 1164–1165 (1968b).
Adamson, R. H., Fabro, S., Hahn, M. A., Creech, C. E., Whang-Peng, J.: Evaluation of the embryotoxic activity of L-asparaginase. Arch. int. Pharmacodyn. 186, 310–320 (1970).
Allison, J. P., Mandy, W. J., Kitto, G. B.: The substrate specificity of L-asparaginase from Alcaligenes eutrophus. FEBS Let. 14, 107–108 (1971).
Altenbern, R. A., Housewright, R. D.: Stereospecific asparaginases in smooth Brucella abortus strain 19. Arch. Biochem. Biophys. 49, 130–137 (1954).
Arens, A., Rauenbuch, E., Irion, E., Wagner, O., Bauer, K., Kaufmann,W.: Isolation and properties of L-asparaginase from Escherichia coli. Hoppe-Seylers Z. Physiol. Chem. 351, 197–212 (1970).
Arfin, S. M.: Asparagine synthesis in the chick embryo liver. Biochim. biophys. Acta (Amst.) 136, 233–244 (1967).
Astaldi, G., Burgio, G. R., Biscatti, G., Astaldi, A., Jr., Ferfoglia, L.: L-Asparaginase and blastogenesis. Lancet II, 643–644 (1969b).
Astaldi, G., Burgio, G. R., KRC, J., Genova, R., Astaldi, A., Jr.: L-Asparaginase and blastogenesis. Lancet I, 423 (1969 a). Astaldi, G., Micu, D., Astaldi, A., Jr., Burgio, G. R., KRC, I.: Further investigations on L-asparaginase and immune reactions. Colloq. Intern. Centre Natl. Rech. Scien. (Paris) 197, 205–219 (1971).
Astaldi, G., Micu, D., Astaldi, A., Jr., Burgio, G. R.: Immunosuppressive action of L-as-paraginase. Lancet II, 1357 (1969 c).
Astaldi, G., Micu, D., Astaldi, A., Jr., Burgio, G. R.: Immunological effect of E. coli L-as-paraginase. Blut 21, 273–282 (1970).
Bauer, K.: Zur Biochemie der Asparaginase. Med. Klin. 64, 9–12 (1969).
Becker, F. F., Baserga, R., Broome, J. D.: Effect of L-asparaginase on DNA synthesis in regenerating liver and in other dividing tissues. Cancer Res. 30, 133–137 (1970).
Becker, F. F., Broome, J. D.: L-Asparaginase: inhibition of early mitosis in regenerating rat liver. Science 156, 1602–1603 (1967).
Becker, F. F., Broome, J. D.: L-Asparaginase: inhibition of endogenous RNA polymerase activity in regenerating liver. Arch. Biochem. Biophys. 130, 332–336 (1969).
Begemann, H., Kaboth, W., Fink, U., Theml, H.: Clinical studies on treatment of auto- immunological disorders with L-asparaginase. Colloq. Intern. Centre Natl. Rech. Scien. (Paris) 197, 195–198 (1971).
Benezra, D., Hochman, A., Pitaro, R.: L-Asparaginase and blastogenesis. Lancet I, 1235–1236 (1970).
Benson, J. V., Jr., Gordon, M. J., Patterson, J. A.: Accelerated chromatographic analysis of amino acids in physiological fluids containing glutamine and asparagine. Anal. Biochem. 18, 228–240 (1967).
Berenbaum, M. C.: Immunosuppression by L-asparaginase. Nature (Lond.) 225, 550–552 (1970).
Berenbaum, M. C., Bondurant, S.: Effect of L-asparaginase on germinal centre haemolysin. Nature (Lond.) 231, 318–319 (1971).
Berenbaum, M. C., Ginsburg, H., Gilbert, D. M.: Effects of L-asparaginase on lymphocyte- target cell reactions in vitro. Nature (Lond.) 227, 1147–1148 (1970).
Bertelli, A., Donati, L., Tbabucchi, E., Jr.: Prolonged survival of allo- and xeno-grafts of skin by means of an antitumoral compound: the L-asparaginase. Arch. ital. pat. 11, 475–479 (1968).
Bilimoria, M. H.: Conditions for the production of L-asparaginase 2 by coliform bacteria. Appl. Microbiol. 18, 1025–1030 (1969).
Bilimoria, M. H., Nisbet, M. A.: The effect of acrolein on L-asparaginase 2 from Escherichia coli. Proc. Soc. exp. Biol. (N.Y.) 130, 698–700 (1971).
Boch, D.: Les conditions d’action de l’asparaginase de l’Aspergillus niger. C.R. Soc. Biol. (Paris) 187, 955–956 (1928).
Bonetti, E., Abbondanza, A., Cobte, E. D., Stibpe, F.: The regulation of L-asparaginase activity in rats and mice. Biochem. J. 115, 597–601 (1969).
Bosmann, H. B.: Asparaginase action: Inhibition of protein synthesis in rat liver mitochondria and microsomes and brain mitochondria and inhibition of glycoprotein synthesis in liver and brain mitochondria by asparaginase. Life Sci. 9, 851–859 (1970).
Bosmann, H. B., Kessel, D.: inhibition of glycoprotein synthesis in L5178Y mouse leukaemic cells by L-asparaginase in vitro. Nature (Lond.) 226, 850 — 851 (1970).
Boyd, J. W., Phillips, A. W.: Purification and properties of L-asparaginase from Serratia marcescens. J. Bact. 106, 578 — 587 (1971).
Boyse, E. A., Old, L. J., Campbell, H. A., Mashbubn, L. T.: Suppression of murine leukemias by L-asparaginase. J. exp. Med. 125, 17–31 (1967).
Boyse, E. A., Old, L. J., Stockert, E.: Inhibitory effect of guinea pig serum on a number of new leukaemias in mice. Nature (Lond.) 198, 800 (1963).
Brambilla, G., Parodi, S., Cavanna, M., Cabaceni, C. E., Baldini, L.: The immunodepressive activity of Escherichia coli L-asparaginase in some transplantation systems. Cancer Res. 30, 2665–2670 (1970).
Breuer, L. H., Warner, R. G., Benton, D. A., Loosli, J. K.: Dietary requirement for aspara- gine and its metabolism in rats. J. Nutr. 88, 143–150 (1966).
Broome, J. D.: Evidence that the L-asparaginase activity of guinea pig serum is responsible for its antilymphoma effects. Nature (Lond.) 191, 1114–1115 (1961).
Broome, J. D.: Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance. J. exp. Med. 118, 99–120 (1963 a).
Broome, J. D.: Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. II. Lymphoma 6C3HED cells cultured in a medium devoid of L-asparagine lose their susceptibility to the effects of guinea pig serum in vivo. J. exp. Med. 118, 121–148 (1963b).
Broome, J. D.: Antilymphoma activity of L-asparaginase in vivo: clearance rates of enzyme preparations from guinea pig serum and yeast in relation to their effect on tumor growth. J. nat. Cancer Inst. 35, 967–974 (1965).
Broome, J. D.: A method for estimating free asparagine and glutamine in biological fluids as trinitrophenyl derivatives. Nature (Lond.) 211, 602–604 (1966).
Broome, J. D.: L-Asparaginase: the evolution of a new tumor inhibitory agent. Trans. N.Y. Acad. Sci. 30, 690–704 (1968a).
Broome, J. D.: Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors. Brit. J. Cancer 22, 595–602 (1968b).
Broome, J. D.: Studies on the mechanism of tumor inhibition by L-asparaginase. J. exp. Med. 127, 1055–1072 (1968c).
Broome, J.D., Schwabtz, J. H.: Differences in the production of L-asparagine in asparaginase- sensitive and resistant lymphoma cells. Biochim. biophys. Acta (Amst.) 138, 637–639 (1967).
Brown, C. H., Ill, Canellos, G. P., Cabbone, P. P.: Effect of L-asparaginase on mouse bone marrow, assayed by in vitro culture. Blood 36, 385–389 (1970).
Burgio, G. R., Astaldi, A., Jr., KRC, I., Micju, D., Astaldi, G.: With reference to blastogenesis inhibition by L-asparaginase. Recent Res. Cancer Res. 33, 288–295 (1970).
Campbell, H. A., Mashburn, L. T.: L-Asparaginase EC-2 from Escherichia coli. Some substrate specificity characteristics. Biochemistry 8, 3768–3775 (1969).
Campbell, H. A., Mashburn, L. T., Boyse, E. A., Old, L.J.: TWO L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity. Biochemistry 6, 721–730 (1967).
Canellos, G. P., Haskell, C. M.: Studies of resistance to L-asparaginase in human leukemia. Recent Res. Cancer Res. 33, 188–193 (1970).
Canellos, G. P., Haskell, C. M., Abseneau, J., Cabbone, P. P.: Hypoalbuminemic and hypocholesterolemic effect of L-asparaginase (NSC-109, 229) treatment in man — a preliminary report. Cancer Chemother. Rep. 53, 67–69 (1969).
Capizzi, R. L., Bertino, J. R., Handschumacher, R. E.: L-Asparaginase. Ann. Rev. Med. 21, 433–444 (1970).
Cedar, H., Schwartz, J. H.: Localization of the two L-asparaginases in anaerobically grown Escherichia coli. J. biol. Chem. 242, 3753–3755 (1967).
Chakrabarty, A. K., Friedman, H.: L-Asparaginase-induced immunosuppression: effects on antibody-forming cells and serum titers. Science 107, 869–870 (1970).
Chaney, P. L., Marbach, E. P.: Modified reagents for determination of urea and ammonia. Clin. Chem. 8, 130–132 (1962).
Chang, T. M. S.: The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma. Nature (Lond.) 229, 117–118 (1971).
Chou, T. C., Handschumacher, R. E.: Kinetic mechanism of L-asparagine synthetase of 6C3HED—RG1 tumor. Fed. Proc. 29, 407 (1970).
Clementi, A.: La désamidation enzymatique de l’asparagine chez les différentes espèce- animales et la signification physiologique de sa présence dans l’organisme. Arch. int. Physiol. 19, 369–398 (1922).
Connors, T. A., Jones, M.: The effect of asparaginase on some animal tumors. Recent Res. Cancer Res. 83, 181–187 (1970).
Cooney, D. A., Capizzi, R. L., Handschumacjher, R. E.: Evaluation of L-asparagine metabolism in animals and man. Cancer Res. 30, 929–935 (1970).
Cooney, D. A., Davis, R. D.: The stability of L-asparaginase with respect to protein dénaturants. Biochim. biophys. Acta (Amst.) 212, 134–138 (1970).
Cooney, D. A., Davis, R. D., Van Atta, G.: A spectrophotometric method for the simultaneous measurement of L-glutamine and L-asparagine in biological materials. Anal. Biochem. 40, 312–326 (1971).
Cooney, D. A., Handscbumacher, R. E.: L-Asparaginase and L-asparagine metabolism. Ann. Rev. Pharmacol. 10, 421–440 (1970).
Dartnall, J. A.: L-Asparaginase and blastogenesis. Lancet II, 1357–1358 (1969).
De-Angeli, L. C., Pocchiari, F., Russi, S., Tonolo, A., Zurita, V. E., Ciaranfi, E., Perin, A.: Effect of L-asparaginase from Aspergillus terreus on ascites sarcoma in the rat. Nature (Lond.) 225, 549–550 (1970).
De Barbieri, A., Astaldi, A., Jr., Micu, D., Mistretta, A. P., Astaldi, G., Burgio, G. R.: Relationship between L-asparaginase blood level and inhibition of lymphocyte blasto-genesis. Boll. 1st. sieroter. Milan. 49, 382–389 (1970).
Debarros, T., Filho, M. C., Ferreira De Santana, C., Valenca, M., Pereira Da Silva, M., Guedes, J., De Carvalho, A. R. L.: Utilizacao de L’asparaginase em paciente humano portador de neoplasia malignana. An. Fac. Med. Recife 25, 21–28 (1965).
De Groot, N., Lichtenstein, N.: The action of Pseudomonas fluorescens extracts on aspara- gine and asparagine derivatives. Biochim. biophys. Acta (Amst.) 40, 99–110 (1960).
Deodhar, S. D.: Enhancement of metastases by L-asparaginase in a mouse tumour system. Nature (Lond.) 281, 319–321 (1971).
Deutsch, E., Fischer, M., Frischauf, H., Honetz, N., Lechner, K., Pesendorfer, F., Stych, H., Weissmann, A.: Blood coagulation changes under L-asparaginase therapy. Recent Res. Cancer Res. 33, 331–341 (1970).
Dolowy, W. C., Elrod, L. M., Ammeraal, R. N., Schrek, R.: Toxicity of L-asparaginase to resistant and susceptible lymphoma cells in vitro. Proc. Soc. exp. Biol. (N. Y.) 125, 598–601 (1967).
Dolowy, W. C., Henson, D., Cornet, J., Sellin, H.: Toxic and antineoplastic effects of L- asparaginase. Cancer 19, 1813–1819 (1966).
Dolowy, W. C., Schrek, R., Henson, D., Cornet, J., Brown, E.: Effects of guinea-pig serum on the Walker 256 carcinosarcoma. Nature (Lond.) 218, 1028–1031 (1968).
Dox, A. W.: The intracellular enzymes of lower fungi, especially those of Pénicillium camemberti. J. biol. Chem. 6, 461–467 (1909).
Eagle, H.: The specific amino acid requirements of a mammalian cell (strain L) in tissue culture. J. biol. Chem. 214, 839–852 (1955).
Ehrman, M., Cedar, H., Schwartz, J. H.: L-Asparaginase II of Escherichia coli. Studies on the enzymatic mechanism of action. J. biol. Chem. 246, 88–94 (1971).
Ellem, K. A. O., Fabrizio, A. M., Jackson, L.: The dependence of DNA and RNA synthesis on protein synthesis in asparaginase-treated lymphoma cells. Cancer Res. 30, 515–527 (1970).
Eremenko, V. V., Evseev, L. P., Nikolaev, A. Y.: Asparaginaza Bacterium cadaveris. Mikro- biologiya 37, 207–212 (1968).
Evseev, L. P., Nikolaev, A. Y.: Indutsirovannoe obrazovanie sintetaz asparagina i gliutamina u Pseudomonas sp. Biokhimiya 33, 1106–1110 (1968).
Fidler, I. J.: L-Asparaginase and metastasis. Lancet I, 777–778 (1970).
Fidler, I. J.: Duration of in vivo effects of L-asparaginase on experimental metastasis. Nature (Lond.) 229, 564 (1971).
Fink, U., Begemann, H.: Clinical studies with L-asparaginase in dermatomyositis. Recent Res. Cancer Res. 33, 329–330 (1970).
Frank, B. H., Pekar, A. H., Veros, A. J., HO, P. P. K.: Crystalline L-asparaginase from Escherichia coli B. II. Physical properties, subunits, and reconstitution behavior. J. biol. Chem. 245, 3716–3724 (1970).
Friedman, H.: L-Asparaginase induced immunosuppression: inhibition of bone marrow derived antibody precursor cells. Science 174, 139–141 (1971).
Frohwein, Y. Z., Friedman, M., Reizer, J., Grossowicz, N.: Sensitive and rapid assay for L-asparaginase. Nature New Biol. 230, 158–159 (1971).
Galaev, Y. V., Kharats, K. S.: Izuchenie aktinvnosfi L-asparaginazy u kishechnol palochki razlichnykh tipov. Zh. Mikrobiol. (mosk.) 46, 127–131 (1969).
Gallo, R. C., Longmore, J. L., Adamson, R. H.: Asparaginyl-tRNA and resistance of murine leukaemias to L-asparaginase. Nature (Lond.) 227, 1134–1136 (1970).
Greenquist, A. C., Wriston, J. C., Jr.: On the structure of L-asparaginase from Escherichia coli B. Fed. Proc. 29, 882 (1970).
Greenstein, J. P., Carter, C. E.: Influence of a-keto acids on the desamidation of amino acid amides. J. nat. Cancer Inst. 7, 57 — 60 (1946).
Greenstein, J. P., Price, V. E.: a-Keto acid-activated glutaminase and asparaginase. J. biol. Chem. 178, 695 — 705 (1949).
Grover, C. E., Chibnall, A. C.: The enzymic deamidation of asparagine in the higher plants. Biochem. J. 21, 857 — 868 (1927).
Guarino, A. M., Söhroeder, D. H., Adamson, R. H., Call, J. B., Gram, T. E.: Studies of hepatic microsomal enzymes, serum proteins, and serum cholesterol after treatment of rats with L-asparaginase alone or in combination with phenobarbital. J. nat. Cancer Inst. 45, 783–787 (1970).
Haley, E. E., Fischer, G. A., Welch, A. D.: The requirement for L-asparagine of mouse leu-kemia cells L5178Y in culture. Cancer Res. 21, 532–536 (1961).
Hall, J. G.: The partitioning of L-asparaginase between blood and lymph. Ree. Res. Cancer Res. 38, 75–80 (1970).
Halpern, Y. S., Grossowicz, N.: Hydrolysis of amides by extracts from mycobacteria. Bio-chem. J. 65, 716–720 (1957).
Handschumacher, R. E.: Asparaginase: chemical structure and its relation to disposition and therapeutic efficacy. Colloq. Intern. Centre Nat. Rech. Seien. (Paris) 197, 377–386 (1971).
Harris, J. E.: Effect of L-asparaginase on the ability of normal mouse bone marrow to form soft agar colonies. Nature (Lond.) 223, 850–851 (1969).
Haskell, C. M., Canellos, G. P.: L-Asparaginase resistance in human leukemia-asparagine synthetase. Biochem. Pharmacol. 18, 2578–2580 (1969).
Haskell, C. M., Canellos, G. P., Cooney, D. A., Hansen, H. H.: Biochemical and pharmacologic effects of L-asparaginase in man. J. Lab. clin. Med. 75, 763–770 (1970).
Heene, D. L., Löffler, H.: The hemostatic defect induced by treatment with asparaginase in leukemia. Recent Res. Cancer Res. 33, 342–343 (1970).
Heinemann, B., Howard, A. J.: Production of tumor-inhibitory L-asparaginase by submerged growth of Serratia marcescens. Appi. Microbiol. 18, 550–554 (1969).
Hersh, E. M.: L-Glutaminase: suppression of lymphocyte blastogenic responses in vitro. Science 172, 736–738 (1971).
Hersh, E. M., Brown, B. W.: Inhibition of immune responses by glutamine antogonism: effect of azotomycin on lymphocyte blastogenesis. Cancer Res. 31, 834–840 (1971).
Hill, J. M., Loeb, E., Hill, N. O., Maclellan, A., Khan, A., Alexander, T. R., Adachi, M.: Treatment of acute leukemia with L-asparaginase. Progr. Antimicrob. Anticancer Chemother. 2, 667–678 (1970).
Hill, J. M., Loeb, E., Maclellan, A., Khan, A., Roberts, J., Shields, W. F., Hill, N. O.: Response to highly purified L-asparaginase during therapy of acute leukemia. Cancer Res. 29, 1574–1580 (1969).
Hill, J. M., Roberts, J., Loeb, E., Khan, A., Maclellan, A., Hill, R. W.: L-Asparaginase therapy for leukemia and other malignant neoplasms. J. Amer. med. Assoc. 202, 882–888 (1967).
Ho, D. H. W., Whitecar, J. P., Jr., Luce, J. K., Frei, E., III: L-Asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow. Cancer Res. 30, 466–472 (1970).
Ho, P. P. K., Frank, B. H., Burck, P. J.: Crystalline L-asparaginase from Escherichia coli B. Science 165, 510–512 (1969).
Ho, P. P. K., Milikin, E. B., Bobbitt, J. L., Grinnan, E. L., Burck, P. J., Frank, B. H., Boeck, L. D., Squires, R. W.: Crystalline L-asparaginase from Escherichia coli B. I. Purification and chemical characterization. J. biol. Chem. 245, 3708–3715 (1970).
Hobik, H. P.: Immunosuppressive Wirkung von L-asparaginase in der Graft-Versus-Host Reaktion. Naturwissenschaften 56, 217 (1969).
Holcenberg, J. S.: Guinea pig asparagine synthetase. Biochim. biophys. Acta (Amst.) 185, 228–238 (1969).
Holcenberg, J. S., Pease, J.: Asparagine synthesis in guinea-pig liver. Biochim. biophys. Acta (Amst.) 158, 500–502 (1968).
Holmquist, N. D.: Effect of normal agouti serum on 6C3HED lymphoma in vivo. Fed. Proc. 21, 166 (1962).
Horowitz, B., Madras, B. K., Meister, A., Old, L. J., Boyse, E. A., Stockert,E.: Asparagine synthetase activity of mouse leukemias. Science 160, 533–535 (1968).
Horowitz, B., Meister, A.: Asparagine synthetase from RADA1 leukemia cells. Colloq. Intern. Centre nat. Rech. Scien. (Paris) 197, 87–91 (1971).
Horowitz, B., Nelson, J. A., Meister, A.: Asparagine synthetase (tumor cells). Meth. Enzymol. 17, 726–732 (1970).
Irion, E., Arens, A.: Biochemical characterization of L-asparaginases from E. coli. Recent Res. Cancer Res. 83, 39–47 (1970).
Jackson, R. C., Handschumacher, R. E.: Escherichia coli L-asparaginase. Catalytic activity and subunit nature. Biochemistry 9, 3585–3590 (1970).
Jahnes, W. G., LI, C. P., Tauraso, N. M.: Studies on inhibition of viral oncogenesis. II. Inhibitory effect of L-asparaginase, clam liver extract and methotrexate on Rous virus focus formation. Arch. ges. Virusforsch. 82, 236–243 (1970).
Jameson, E., Ainis, H., Ryan, R. M.: Action of guinea pig serum and human gamma globulin on growth of a rat tumor. Science 124, 980–981 (1956).
Jameson, E., Ainis, H., Ryan, R. M.: The inhibition by guinea pig serum of the growth of the Murphy-Sturm lymphosarcoma. Cancer Res. 18, 866–868 (1958).
Jayaram, H. N., Ramakrishnan, T., Vaidyanathan, C. S.: L-Asparaginases from Mycobacterium tuberculosis strains H37RW and H37R0. Arch. Biochem. Biophys. 126, 165–174 (1968).
Kessel, D.: Asparaginyl-transfer RNA: a substrate for L-asparaginase. Biochim. biophys. Acta (Amst.) 240, 554–557 (1971).
Kessel, D., Bosmann, H. B.: Effects of L-asparaginase on protein and glycoprotein synthesis. FEBS Let. 10, 85–88 (1970).
Khan, A., Hill, J. M.: Suppression of skin hypersensitivity and antibody formation by L- asparaginase. J. Immunol. 104, 679–684 (1970).
Khan, A., Hill, J. M., Adachi, M.: L-Asparaginase in experimental auto-immune disease: inhibition of allergic encephalomyelitis. J. Immunol. 105, 256–258 (1970).
Kidd, J. G.: Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum. J. exp. Med. 98, 565–582 (1953 a).
Kidd, J. G.: Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. II. Studies on the nature of the active serum constituent: histological mechanism of the regression: tests for effects of guinea pig serum on lymphoma cells in vitro: discussion. J. exp. Med. 98, 583–606 (1953b).
Kidd, J. G.: Effects of arsenic-azoproteins on mouse lymphoma cells in vivo with observations on the effects of other “anti-lymphoma” agents, and on the susceptibility to these effects of lymphoma cells of various types. J. exp. Med. 108, 665–684 (1958).
Kidd, J. G.: Asparaginase and cancer — yesterday and today. Rec. Res. Cancer Res. 38, 3–14 (1970).
Kirschbaum, J., Wriston, J. C., Jr., Ratych, O. T.: Subunit structure of L-asparaginase from Escherichia coli B. Biochim. biophys. Acta (Amst.) 194, 161–169 (1969).
Kojima, Y., Wacker, W. E. C.: An enzymatic method for the measurement of asparagine and a new assay of asparaginase activity. J. Lab. clin. Med. 74, 521–526 (1969).
Kretovich, W. L.: The biosynthesis of dicarboxylic amino acids and enzymic transformations of amides in plants. Advanc. Enzymol. 20, 319–340 (1958).
Kristiansen, T., Einarsson, M., Sundberg, L., Porath, J.: Purification of L-asparaginase from E. coli by specific adsorption and desorption. FEBS Let. 7, 294–296 (1970).
Krzeminski, Z.: Dalsze badania nad dezaminacja aminokwasow drzez Streptococcus mitis. 2. Dezeminacja asparaginy. Cz. Stomat. 22, 249–254 (1969).
Kwak, K. S., Jameson, E., Ryan, R. M., Kurtz, H. M.: The effect of varying implant cell numbers on the inhibitory activity of guinea pig serum on Walker carcinosarcoma 256 in the rat. Cancer Res. 21, 44–47 (1961).
Laboureur, P.: Biochimie de L’asparaginase. Propriétés du système asparaginase et activité biologique. Pathol. Biol. 17, 885–908 (1969).
Laboureur, P., Langlois, C., Labrousse, M., Boudon, M., Emeraud, J., Samain, J. F.: Différentes formes d’asparaginases de E. coli. Colloq. int. Centre nat. Rech. Scien. (Paris) 197, 43–53 (1971).
Lajolo, D., Astaldi, A., Jr., Pecco, P., Bert, G., Astaldi, G.: Electrophoretical mobility of human lymphocytes in the presence of E. coli L-asparaginase. Exp. cell Res. 60, 458–459 (1970).
Lang, S.: Über Desamidierung im Tierkörper. Beitr. ehem. Physiol. Path. 5, 321–345 (1904).
Lauenstein, K., Grundmann, E., Hobik, H. P., Madaus, W. P.: Experimental immunosuppression with L-asparaginase. Recent Res. Cancer Res. 33, 170–173 (1970).
Lauinger, C., Ressler, C.: β-Cyanoalanine as a substrate for asparaginase. Stoichiometry, kinetics, and inhibition. Biochim. biophys. Acta (Amst.) 198, 316–323 (1970).
Lees, E. M., Blakeney, A. B.: The distribution of asparaginase activity in legumes. Biochim. biophys. Acta (Amst.) 215, 145–151 (1970).
Levintow, L.: Evidence that glutamine is a precursor of asparagine in a human cell in tissue culture. Science 126, 611–612 (1957).
Litt, Y. P., Handschumacher, R. E.: Chemical modification of L-asparaginase. Proc. Amer. Ass. Cancer Res. 12, 99 (1971).
Lorke, D., Tettenborn, D.: Experimental studies on the toxicity of crasnitin in animals. Recent Res. Cancer Res. 33, 174–180 (1970).
Maral, R., Guyonnet, J. C., Julou, L., Deratuld, Y., Werner, G. H.: Studies on the immunosuppressive activity of L-asparaginase. Ree. Res. Cancer Res. 33, 160–169 (1970).
Maral, R., Werner, G. H.: Antiviral activity of L-asparaginase. Nature New Biol. 232, 187–188 (1971).
Mardashev, S. R., Shao, H. W.: Purification of guinea pig serum asparaginase by chromatography on a diethylaminoethyl cellulose column. Dokl. Akad. Nauk. S.S.S.R. 142, 21–24 (1967).
Marquardt, H.: L-Asparaginase — das erste spezifische Cytostaticum. Arzneimittel-Forsch. 18, 1380–1386 (1968).
Mashburn, L. T., Gordon, C. S.: The effects of L-asparaginase on the amino acid incorporation of mouse lymphoid tumors. Cancer Res. 28, 961–967 (1968).
Mashburn, L. T., Landin, L. M.: Changes in ribonuclease activities in P1798 lymphosarcoma after asparaginase treatment. Arch. Biochem. Biophys. 125, 721–726 (1968).
Mashburn, L. T., Landin, L. M.: Some physicochemical aspects of L-asparaginase therapy. Recent Res. Cancer Res. 33, 48–57 (1970).
Mashburn, L. T., Wriston, J. C., Jr.: Tumor inhibitory effect of L-asparaginase. Biochem. biophys. Res. Commun. 12, 50–55 (1963).
Mashburn, L. T., Wriston, J. C., Jr.: Tumor inhibitory effect of L-asparaginase from Escherichia coli. Arch. Biochem. Biophys. 105, 450–452 (1964).
Mashburn, L. T., Wriston, J. C., Jr.: Change in ribonuclease concentrations in L-asparaginase- treated lymphosarcomata. Nature (Lond.) 211, 1403–1404 (1966).
McCoy, T. A., Maxwell, M., Irvine, E., Sartorelli, A. C.: TWO nutritional variants of cultured Jensen sarcoma cells. Proc. Soc. exp. Biol. (N. Y.) 100, 862 — 865 (1959b).
McCoy, T. A., Maxwell, M., Kruse, P. F., Jr.: The amino acid requirements of the Jensen sarcoma in vitro. Cancer Res. 19, 591–595 (1959a).
McElwain, T. J., Hayward, S. K.: L-Asparaginase and blastogenesis. Lancet I, 527 (1969).
Meister, A.: Glutaminase, asparaginase, and a-keto acid-co-amidase. B. L-Asparaginase from guinea pig serum. Meth. Enzymol. 2, 383–385 (1955).
Meister, A.: Intermediary metabolism of the amino acids. In: Meister, A. (Ed.): Biochemistry of the Amino Acids, Vol. II, 2 nd. Edition,pp. 606–617. New York: Academic Press 1965.
Meister, A., Sober, H. A., Tice, S. V., Fraser, P. E.: Transamination and associated deamidation of asparagine and glutamine. J. biol. Chem. 197, 319–330 (1952).
Micou, D., Astaldi, G., Astaldi, A., Jr., Mihailesco, E., Lisiewicz, J.: L’effet de la L-as- paraginase sur les cellules de la série plasmocytaire. Schweiz, med. Wschr. 100, 1997–1999 (1970).
Mikucki, J., Szabapinska-Kwaszewska, J., Krzeminski, Z.: Aktywnoéé asparaginazy u anty- biotykoopornych gronkowcow ziocistych. Med. Doswiadczalna Mikrobiol. 20, 227–231 (1968).
Miller, D. S., Marlborough, D. I., Cammaök, K. A.: Physical properties and subunit structure of L-asparaginase isolated from Erwinia carotovora. Colloq. int. Centre nat. Rech. Seien. (Paris) 197, 55–71 (1971).
Miller, H. K., Balis, M. E.: Glutaminase activity of L-asparagine amidohydrolase. Biochem. Pharmacol. 18, 2225–2232 (1969).
Miller, H. K., Krakoff, I. H., Salser, J. S., Balis, M. E.: Sensitivity to L-asparaginase and amino acid metabolism. J. nat. Cancer Inst. 44, 1129–1139 (1970).
Miller, H. K., Salser, J. S., Balis, M. E.: Amino acid levels following L-asparagine amidohydrolase (EC. 3.5.1.1) therapy. Cancer Res. 29, 183–187 (1969).
Miller, J. F. A. P., Mitchell, G. F.: Thymus and antigen reactive cells. Transplant. Rev. 1, 3–42 (1969).
Mittra, M., Hirano, M., Kakizawa, K., Morita, A., Uetani, T., Yamada, K.: Inhibitory effect of L-asparaginase in lymphocyte transformation induced by phytohemagglutinin. Cancer Res. 30, 768–772 (1970a).
Miura, M., Hirano, M., Kakizawa, K., Morita, A., Uetani, T., Yamada, K.: Antitumor activity of L-β-aspartohydroxamic acid in vivo. Screening data of 21 L-asparagine related compounds. Progr. antimicrob. anticancer Chemotherapy 2, 170 — 174 (1970b).
Miura, M., Kawashima, K., Uetani, T., Hirano, M., Kakizawa, H., Ohno, R., Morita, A., Nishiwaki, H., Yamada, K.: Influence of L-asparaginase on antibody production and growth of tumors in allogeneic mice. Cancer Res. 31, 114–121 (1971).
Morrow, J.: Mutation rate from asparagine requirement to asparagine non-requirement. J. cell. Physiol. 77, 423–425 (1971).
Nahorski, S. R.: Fluorometric measurement of glutamine and asparagine using enzyme methods. Anal. Biochem. 42, 136–142 (1971).
Nakamura, N., Morikawa, Y., Tanaka, M.: L-Asparaginase from Escherichia coli. II. Sub-strate specificity studies. Agr. biol. Chem. 35, 743–751 (1971).
Nelson, S. D., Lee, M. B., Bridges, J. M.: Immunosuppressive activity of L-asparaginase in mice. Transplantation 9, 566–570 (1970).
Neuman, R. E., McCoy, T. A., The dual requirement of the Walker carcinosarcoma 256 in vitro for asparagine and glutamine. Science 124, 124–125 (1956).
Nicolin, A., Napoli, P. A.: Azione favorente delia levo-asparaginasi sulla crescita del car-cinoma ascite di Ehrlich (in animali normali o in animali previamente “vaccinati” verso lo stesso tumore ascitico). Arch. ital. Pat. 12, 177–187 (1969).
Nishimura, Y., Makino, H., Takenaka, O., Inada,Y.: Amino acid residues in asparaginase (Escherichia coli HAP) associated with its enzymic activity. Biochim. biophys. Acta (Amst.) 227, 171–179 (1971).
North, A. C. T., Wade, H. E., Cammack, K. A.: Physiochemical studies of L-asparaginase from Erwinia carotovora. Nature (Lond.) 224, 594–595 (1967).
Oettgen, H. F., Old, L. J., Boyse, E. A., Campbell, H. A., Philips, F. S., Clarkson, B. D., Tallal, L., Leeper, R. D., Schwartz, M. K., Kim, J. H.: Inhibition of leukemias in man by L-asparaginase. Cancer Res. 27, 2619–2631 (1967).
Ohno, R., Harris, J. E., Hersh, E. M.: L-Asparaginase: suppression of the immune response of mice to sheep red blood cells. Clin. exp. Immunol. 7, 221–227 (1970).
Ohno, R., Hersh, E. M.: Immunosuppressive effects of L-asparaginase. Cancer Res. 30, 1605–1611 (1970a).
Ohno, R., Hersh, E. M.: The inhibition of lymphocyte blastogenesis by L-asparaginase (LA). Blood 35, 250–262 (1970b).
Ohnuma, T., Bergel, F., Bray, R. C.: Enzymes in cancer. Asparaginase from chicken liver. Biochem. J. 103, 238–245 (1967).
Ohnuma, T., Holland, J. F., Freeman, A., Sinks, L. F.: Biochemical and pharmacological studies with asparaginase in man. Cancer Res. 30, 2297–2305 (1970).
Old, L. J., Boyse, E. A., Campbell, H. A.: L-Asparagine and leukemia. Sci. Amer. 219, 34–40 (1968).
Old, L. J., Boyse, E. A., Campbell, H. A., Daria, G. M.: Leukaemia-inhibiting properties and L-asparaginase activity of sera from certain South American rodents. Nature (Lond.) 198, 801 (1963).
Osoba, D.: Restriction of the capacity to respond to two antigens by single precursors of antibody-producing cells in culture. J. exp. Med. 129, 141–152 (1969).
Patterson, M.K., Jr.: Studies on the control of asparagine biosynthesis in mammalian tissues. Rec. Res. Cancer Res. 33, 22–30 (1970).
Patterson, M.K., Jr.: Effects of L-asparaginase on asparagine synthetase levels of normal and malignant tissues. Colloq. int. Centre nat. Rech. Scien. (Paris) 197, 107–113 (1971).
Patterson, M. K., Jr., Conway, E., Whittle, W., McCoy, T. A.: In vitro effects of guinea pig serum on the Jensen, JA-1 and JA-2 sarcomas. Proc. Soc. exp. Biol. (N.Y.) 119, 5–9 (1965).
Patterson, M. K., Jr., Maxwell, M. D.: Effects of L-asparagine deprivation on the cell cycle of the Jensen sarcoma. Cancer Res. 30, 1064–1067 (1970).
Patterson, M. K., Jr., Maxwell, M. D., Conway, E.: Studies on the asparagine requirement of the Jensen sarcoma and the derivation of its nutritional variant. Cancer Res. 29, 296–300 (1969).
Patterson, M. K., Jr., Orr, G.: L-Asparagine biosynthesis by nutritional variants of the Jensen sarcoma. Biochem. biophys. Res. Commun. 26, 228–233 (1967).
Patterson, M. K., Jr., Orr, G. R.: Asparagine biosynthesis by the Novikoff hepatoma. Isola-tion, purification, property, and mechanism studies of the enzyme system. J. biol. Chem. 243, 376–380 (1968).
Patterson, M. K., Jr., Orr, G. R.: Regeneration, tumor, dietary, and L-asparaginase effects on asparagine biosynthesis in rat liver. Cancer Res. 29, 1179–1183 (1969).
Patterson, M. K., Jr., Orr, G. R., McCoy, T. A.: Asparagine-C14 and glutamine-C14 from animal cell protein and their chemical degradation. Anal. Biochem. 6, 543–548 (1963).
Peters, J. H., Lin, S. C., Berridge, B. J., Jr., Ceao, W. R., Cummings, J. G.: Circulatory L- asparaginase activity in primates. Life Sci. 9, 431–436 (1970).
Peterson, R. E., Ciegler, A.: L-Asparaginase production by various bacteria. Appl. Microbiol. 17, 929–930 (1969a).
Peterson, R. E., Ciegler, A.: L-Asparaginase production by Erwinia aroideae. Appl. Microbiol. 18, 64–67 (1969b).
Peterson, R.G., Handschumacher, R. E., Mitchell, M. S.: Immunological responses to L- asparaginase. J. clin. Invest. 50, 1080–1090 (1971).
Prager, M. D., Bachynsky, N.: Asparagine synthetase in asparaginase resistant and susceptible mouse lymphomas. Biochem. biophys. Res. Commun. 31, 43–47 (1968a).
Prager, M. D., Bachynsky, N.: Asparagine synthetase in normal and malignant tissues; correlation with tumor sensitivity to asparaginase. Arch. Biochem. Biophys. 127, 645–654 (1968b).
Prager, M. D., Derr, I.: Inhibition of primary antibody response by E. coli asparaginase. Nature (Lond.) 225, 952 (1970).
Prager, M. D., Derr, I.: Metabolism of asparagine, aspartate, glutamine, and glutamate in lymphoid tissue: basis for immunosuppression by L-asparaginase. J. Immunol. 106, 975–979 (1971).
Prusiner, S., Milner, L.: A rapid radioactive assay for glutamine synthetase, glutaminase, asparagine synthetase and asparaginase. Anal. Biochem. 37, 429–438 (1970).
Putter, J.: Pharmacokinetic behavior of L-asparaginase in men and in animals. Recent Res. Cancer Res. 33, 64–74 (1970).
Rauenbusch, E., Batjer, K., Kaufmann, W., Wagner, O.: Isolation and crystallization of L-asparaginase from E. coli. Recent Res. Cancer Res. 33, 31–38 (1970).
Rauenbusch, E., Irion, E., Arens, A.: The subunits of L-asparaginase from Escherichia coli. Colloq. int. Centre nat. Rech. Scien. (Paris) 197, 31–42 (1971).
Ravel, J. M., Norton, S. J., Humphreys, J. S., Shive, W.: Asparagine biosynthesis in Lactobacillus arabinosus and its control by asparagine through enzyme inhibition and repression. J. biol. Chem. 237, 2845–2849 (1962).
Reddy, V. V. S., Jayaram, H. N., Sirsi, M., Ramakrishnan, T.: Inhibitory activity of L-as-paraginase from Mycobacterium tuberculosis on Yoshida ascites sarcoma in rats. Arch. Biochem. Biophys. 132, 262–267 (1969).
Riley, V.: Influence of a benign virus upon mouse leukemia during asparaginase therapy. Path, et Biol. 18, 757–764 (1970).
Riley, V., Spaceman, D. H., Fitzmaurice, M. A.: Critical influence of an enzyme-elevating virus upon long-term remissions of mouse leukemia following asparaginase therapy. Recent Res. Cancer Res. 33, 81–101 (1970).
Roberts, J., Burson, G., Hill, J. M.: New procedures for purification of L-asparaginase with high yield from Escherichia coli. J. Bact. 95, 2117–2123 (1968).
Roberts, J., Prager, M. D., Bachynsky, N.: The antitumor activity of Escherichia coli L-as- paraginase. Cancer Res. 26, 2213–2217 (1966).
Robison, R. S., Berk, B.: L-Asparaginase synthesis by Escherichia coli B. Biotechnol. Bioeng. 11, 1211–1225 (1969).
Rowley, B., Wriston, J. C., Jr.: Partial purification and antilymphoma activity of Serratia marcescens L-asparaginase. Biochem. biophys. Res. Commun. 28, 160–165 (1967).
Rudman, D., Vogler, W. R., Howard, C. H., Gerron, G. G.: Observations on the plasma amino acids of patients with acute leukemia. Cancer Res. 31, 1159–1165 (1971).
Ryan, W. L., Dworak, J. E.: Amino acids of the 6C3HED lymphosarcoma following treatment with asparaginase. Cancer Res. 30, 1206–1209 (1970).
Ryan, W. L., Sornson, H. C.: Glycine inhibition of asparaginase. Science 167, 1512–1513 (1970).
St. Pierre, R. L., Tennenbaum, J. I., Folk, R. M.: L-Asparaginase and allograft immunity. Lancet II, 1365–1366 (1970).
Scheetz, R. W., Whelan, H. A., Wriston, J. C., Jr.: Purification and properties of an L-as- paraginase from Fusarium tricinctum. Arch. Biochem. Biophys. 142, 184–189 (1971).
Schein, P. S., Rakieten, N., Gordon, B. M., Davis,R. D., Rall, D. P.: The toxicity of Esche-richia coli L-asparaginase. Cancer Res. 29, 426–434 (1969).
Schrek, R., Dolowy, W. C., Ammeraal, R. N.: L-Asparaginase: toxicity to normal and leu-kemic human lymphocytes. Science 155, 329–330 (1967).
Schulten, H. K., Giraldo, G.: Influence of L-asparaginase preparations of E. coli and Agouti serum on the homograft reactivity in the mouse. Recent Res. Cancer Res. 33, 155–159 (1970).
Schulten, H. K., Gibaldo, G., Boyse, E. A., Oettgen, H. F.: Immunosuppressive action of L-asparaginase. Lancet II, 644–645 (1969).
Schwartz, J. H., Reeves, J. Y., Broome, J. D.: Two L-asparaginases from E. coli and their action against tumors. Proc. nat. Acad. Sei. (Wash.) 56, 1516–1519 (1966).
Schwartz, M. K.: The distribution and clearance of L-asparaginase. Recent Res. Cancer Res. 33, 58–63 (1970).
Schwartz, M. K., Lash, E. D., Oettgen, H. F., Tomao, F. A.: L-Asparaginase activity in plasma and other biological fluids. Cancer 25, 244–252 (1970).
Schwartz, R. S.: Immunosuppression by L-asparaginase. Nature (Lond.) 224, 275–276 (1969).
Seeber, S., Warneoke, P., Straub, O. C.: Zum Einfluß von E. coZi-L-asparaginase auf den Nucleinsäurestoffwechsel lymphatischer Rinderleukämiezellen. Arzneimittel-Forsch. 19, 1745–1748 (1969).
Seeber, S., Weser, U.: Inhibition of 3H-thymidine incorporation into rat liver nuclei by E. coli L-asparaginase. Nature (Lond.) 225, 652–653 (1970).
Serba, J. A.: Regulatory genetic changes in the origin of asparaginase-sensitive leukemias. Tenth International Cancer Congress, Abstr. 359–360 (1970).
Shaw, M. T., Barnes, C.C., Madden, F. J. F., Bagshawe, K. D.: L-Asparaginase and pancreatitis. Lancet II, 721 (1970).
Shons, A., Jetzer, T., Najarian, J. S.: Prolongation of skin homograft survival by L-asparagin- ase. Transplantation 10, 280–281 (1970).
Simberkoff, M. S., Thomas, L.: Reversal by L-glutamine of the inhibition of lymphocyte mitosis caused by E. coli asparaginase. Proc. Soc. exp. Biol. (N. Y.) 133, 642–644 (1970).
Simberkoff, M. S., Thorbecke, G. J., Thomas, L.: Studies of PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by mycoplasmal extracts. J. exp. Med. 129, 1163–1181 (1969).
Sinclair, N. R. ST. C., Elliott, E. V.: Neonatal thymectomy and hemolysin responses in in-bred mice. J. Immunol. 101, 251–255 (1968).
Sobin, L. H., Kidd, J. G.: A metabolic difference between two lines of lymphoma 6C3HED cells in relation to asparagine. Proc. Soc. exp. Biol. (N.Y.) 119, 325–327 (1965).
Sobin, L. H., Kidd, J. G.: Alterations in protein and nucleic acid metabolism of lymphoma 6C3HED—OG cells in mice given guinea pig serum. J. exp. Med. 123, 55–74 (1966).
Staerk, J., Zwisler, O., Ronneberger, H.: A comparison of L-asparaginase from Erwinia aroideae and from Escherichia coli: biochemical and biological properties. Experientia (Basel) 27, 250–252 (1971).
Steensholt, G.: On the distribution of asparaginase. Acta physiol. scand. 8, 342–347 (1944).
Suld, H. M., Herbut, P. A.: Guinea pig serum and liver asparaginases. Purification and anti-tumor activity. J. biol. Chem. 240, 2234–2241 (1965).
Suld, H. M., Herbut, P. A.: Guinea pig serum and liver L-asparaginases. Comparison of serum and papain-digested liver L-asparaginases. J. biol. Chem. 245, 2797–2801 (1970a).
Suld, H. M., Herbut, P. A.: Immunological studies on guinea pig serum and liver L-asparaginases. Purification of L-asparaginases by antibody precipitation. J. biol. Chem. 245, 2802–2808 (1970b).
Tanaka, M., Kagawa, T., Tatano, T., Mochizuki, K., Nakamura, N., Kohagura, M., Hill, J. M.: Antineoplastic crystalline L-asparaginase from E. coli. Progr. antimicrob. anticancer Chemother. 2, 260–266 (1970).
Tower, D. B., Peters, E. L., Curtis, W. C.: Guinea pig serum L-asparaginase. Properties, purification, and application to determination of asparagine in biological samples. J. biol. Chem. 238, 983–993 (1963).
Tsuji, Y.: Amidase action of bacteria. Naika Hokan. 4, 222–223 (1957).
Ubuka, T., Meister, A.: Studies on the utilization of asparagine by mouse leukemia cells. J. nat. Cancer Inst. 46, 291–298 (1971).
Vadlamudi, S., Padarathsingh, M., Bonmassar, E., Waravdekar, V., Goldin, A.: Studies on neutralization of L-asparaginase activity in vitro and in vivo. Cancer 27, 1321–1327 (1971).
Vadlamudi, S., Padarathsingh, M., Waravdekar, V. S., Goldin, A.: Factors influencing the therapeutic activity of L-asparaginase (NSC 109229) in leukemic (L5178Y) mice. Cancer Res. 30, 1467–1472 (1970).
Von Furth, O., Friedmann, M.: Über die Verbreitung asparaginspaltender Organfermente. Biochem. Z. 26, 435–440 (1910).
Wade, H. E., Elsworth, R., Herbert, D., Keppie, J., Sargeant, K.: A new L-asparaginase with antitumour activity. Lancet II, 776–777 (1968).
Wagner, O., Bauer, K., Irion, E., Rauenbusöh, E., Kaufmann, W., Arens, A.: Polyäthylenglykol zur Anreicherung und Kristallisation von L-Asparaginase. Angew. Chem. 81, 904–905 (1969a).
Wagner, O., Irion, E., Bauer, K.: Partially deaminated L-asparaginase. Biochem. biophys, Res. Commun. 37, 383–392 (1969b).
Weinberger, S.: L-Asparaginase as an antitumor agent. Enzyme 12, 143–159 (1971).
Weiner, M. S., Waithe, W. I., Hirschhorn, K.: L-Asparaginase and blastogenesis. Lancet II, 748 (1969).
Weksler, M. E., Weksler, B. B.: Studies on the immunosuppressive properties of asparagin-ase. Immunology 21, 137–150 (1971).
Whelan, H. A., Wriston, J. C., Jr.: Purification and properties of asparaginase from Escherichia coli B. Biochemistry 8, 2386–2393 (1969).
Whitecar, J. P.,Jr.,Bodey, G. P., Hill, C. S., Jr., Samaan, N. A.: Effect of L-asparaginase on carbohydrate metabolism. Metabolism 19, 581–586 (1970).
Woods, J. S., Lee, I. P., Dixon, R. L.: Asparagine incorporation into the DNA of hepatic and 6C3HED murine lymphosarcoma cells. Cancer Res. 30, 1210–1211 (1970).
Wriston, J. C., Jr.: Asparaginase. Meth. Enzymol. 17, 732 — 742 (1970).
Wriston, J. C., Jr.: L-Asparaginase. Enzymes 4, 101 — 121 (1971a).
Wriston, J. C., Jr.: On the structure of E. coli B asparaginase. Colloq. int. Centre nat. Rech. Seien. (Paris) 197, 25–29 (1971b).
Yellin, T. O., Wriston, J.C., Jr.: Purification and properties of guinea pig serum asparaginase. Biochemistry 5, 1605–1612 (1966).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 springer-Verlag Berlin-Heidelberg
About this chapter
Cite this chapter
Patterson, M.K. (1975). L-Asparaginase: Basic Aspects. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65806-8_39
Download citation
DOI: https://doi.org/10.1007/978-3-642-65806-8_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65808-2
Online ISBN: 978-3-642-65806-8
eBook Packages: Springer Book Archive